Lung Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older
- People who have a confirmed diagnosis of lung cancer (either non-small cell lung cancer, small cell lung cancer, or a carcinoid tumor), confirmed through a tissue sample analysis
- People whose lung cancer was diagnosed either at the time of joining the study or within the past 12 months
- People whose full care — including diagnosis, treatment, and follow-up — is being managed in the oncology or lung disease department of one of the 21 participating public or university hospitals
- People who have signed a consent form agreeing to take part in the study
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously been enrolled in this same study
- People who are currently taking part in another clinical trial that involves an active intervention (such as testing a treatment)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adda BOUNEDJAR, Professor of Medical Oncology, Frantz Fanon University Hospital, Cancer Center (CAC), Blida, Algeria
Phone: +213 770 48 43 36
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sociodemographic and clinical characteristics of lung cancer patients in Algeria; Histological type and stage of lung cancer at diagnosis; Molecular profile of tumors; First-line treatment modalities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.